Vanguard Group Inc Nautilus Biotechnology, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,485,081 shares of NAUT stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,485,081
Previous 2,772,708 10.37%
Holding current value
$2.78 Million
Previous $2.38 Million 24.96%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$0.67 - $0.93 $192,710 - $267,493
-287,627 Reduced 10.37%
2,485,081 $1.79 Million
Q1 2025

May 09, 2025
SELL
$0.86 - $2.04 $4,937 - $11,711
-5,741 Reduced 0.21%
2,772,708 $2.38 Million
Q4 2024

Feb 11, 2025
BUY
$1.67 - $2.96 $20,217 - $35,833
12,106 Added 0.44%
2,778,449 $4.67 Million
Q3 2024

Nov 13, 2024
BUY
$2.24 - $3.08 $95,753 - $131,660
42,747 Added 1.57%
2,766,343 $7.88 Million
Q2 2024

Aug 13, 2024
SELL
$2.22 - $3.0 $301,489 - $407,418
-135,806 Reduced 4.75%
2,723,596 $6.37 Million
Q1 2024

May 10, 2024
BUY
$2.41 - $3.18 $71,345 - $94,140
29,604 Added 1.05%
2,859,402 $8.41 Million
Q4 2023

Feb 14, 2024
BUY
$2.34 - $3.39 $50,574 - $73,268
21,613 Added 0.77%
2,829,798 $8.46 Million
Q3 2023

Nov 14, 2023
BUY
$2.87 - $3.94 $18,020 - $24,739
6,279 Added 0.22%
2,808,185 $8.87 Million
Q2 2023

Aug 14, 2023
SELL
$2.21 - $4.52 $84,631 - $173,093
-38,295 Reduced 1.35%
2,801,906 $10.8 Million
Q1 2023

May 15, 2023
BUY
$1.67 - $2.77 $1.11 Million - $1.84 Million
664,825 Added 30.56%
2,840,201 $7.87 Million
Q4 2022

Feb 10, 2023
SELL
$1.55 - $2.47 $2,035 - $3,243
-1,313 Reduced 0.06%
2,175,376 $3.92 Million
Q3 2022

Nov 14, 2022
SELL
$1.96 - $3.13 $7,116 - $11,365
-3,631 Reduced 0.17%
2,176,689 $4.61 Million
Q2 2022

Aug 12, 2022
SELL
$2.64 - $4.84 $453,063 - $830,616
-171,615 Reduced 7.3%
2,180,320 $5.87 Million
Q1 2022

May 13, 2022
BUY
$3.5 - $5.3 $3.73 Million - $5.65 Million
1,066,638 Added 82.99%
2,351,935 $10.2 Million
Q4 2021

Feb 14, 2022
BUY
$4.45 - $6.21 $3.11 Million - $4.34 Million
699,435 Added 119.39%
1,285,297 $6.66 Million
Q3 2021

Nov 12, 2021
BUY
$6.14 - $10.1 $3.6 Million - $5.92 Million
585,862 New
585,862 $3.6 Million

Others Institutions Holding NAUT

# of Institutions
75
Shares Held
63.4M
Call Options Held
158K
Put Options Held
0
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $140M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email